Sunnyvale, United States
NimbleHeart, founded in 2012, has positioned itself at the forefront of cardiac monitoring technology with its pioneering FDA-approved exercise wearable ECG cardiac monitor. As the first device of its kind, NimbleHeart promotes heart health through both real-time and post-session monitoring, aimed specifically at the "at-risk" population.
Backed by funding from founders and angel investors based in the US, India, Dubai, Singapore, and Co-Creation Capital, NimbleHeart exemplifies a robust international collaboration. The firm recently secured a $750.00K Seed Round investment on 19 July 2021, highlighting investor confidence in its proprietary, wirelessly connected ECG platform.
Headquartered in the United States, the company operates within the Health Care, Health and Wellness, Manufacturing, and Medical Devices industries. Through a multidisciplinary team skilled in mechanical and electrical design, mobile software development, and signal processing, NimbleHeart aims to bring clinical-level cardiac care into the comfort of users' homes.
